JPWO2022259907A1 - - Google Patents
Info
- Publication number
- JPWO2022259907A1 JPWO2022259907A1 JP2023527628A JP2023527628A JPWO2022259907A1 JP WO2022259907 A1 JPWO2022259907 A1 JP WO2022259907A1 JP 2023527628 A JP2023527628 A JP 2023527628A JP 2023527628 A JP2023527628 A JP 2023527628A JP WO2022259907 A1 JPWO2022259907 A1 JP WO2022259907A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021097781 | 2021-06-11 | ||
PCT/JP2022/022056 WO2022259907A1 (ja) | 2021-06-11 | 2022-05-31 | シリコン微粒子を含有する疾患の予防又は治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPWO2022259907A1 true JPWO2022259907A1 (ja) | 2022-12-15 |
Family
ID=84424944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023527628A Pending JPWO2022259907A1 (ja) | 2021-06-11 | 2022-05-31 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20240269165A1 (ja) |
EP (1) | EP4353241A4 (ja) |
JP (1) | JPWO2022259907A1 (ja) |
CN (1) | CN117396212A (ja) |
WO (1) | WO2022259907A1 (ja) |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110311452A1 (en) * | 2008-12-23 | 2011-12-22 | Board Of Regents Of The University Of Texas System | Inflammation targeting particles |
JP2013227253A (ja) * | 2012-04-25 | 2013-11-07 | Univ Of Tokyo | 蛍光シリコンナノ粒子を用いた薬物送達システム |
US20170065659A1 (en) * | 2015-09-07 | 2017-03-09 | Birgit Christine SKORPEN | Composition for use in treating and/or preventing human condition, disorder or diseases |
US20170196944A1 (en) * | 2015-09-28 | 2017-07-13 | Robert Portman | Method to reduce muscle atrophy following orthopedic surgery |
WO2018037818A1 (ja) | 2016-08-23 | 2018-03-01 | 小林 光 | 水素供給材及びその製造方法、並びに水素供給方法 |
WO2018037819A1 (ja) | 2016-08-23 | 2018-03-01 | 小林 光 | 配合物及びその製造方法、並びに水素供給方法 |
WO2019021769A1 (ja) | 2017-07-27 | 2019-01-31 | 国立大学法人大阪大学 | 薬剤及びその製造方法 |
WO2019211960A1 (ja) | 2018-04-29 | 2019-11-07 | 株式会社Kit | 複合組成物 |
JP7333941B2 (ja) | 2018-06-07 | 2023-08-28 | 国立大学法人大阪大学 | 酸化ストレスに起因する疾患の予防又は治療剤 |
CN112351783A (zh) | 2018-06-07 | 2021-02-09 | 国立大学法人大阪大学 | 氧化应激诱发的疾病的预防或治疗药物 |
JP7345824B2 (ja) | 2018-07-02 | 2023-09-19 | 国立大学法人大阪大学 | うつ病又はうつ状態の予防又は治療剤 |
JP7461003B2 (ja) | 2018-11-13 | 2024-04-03 | 国立大学法人大阪大学 | パーキンソン病の予防又は治療剤 |
JP2020079228A (ja) | 2018-11-13 | 2020-05-28 | 国立大学法人大阪大学 | 二日酔いの予防又は治療剤 |
JP7461006B2 (ja) | 2019-01-24 | 2024-04-03 | 国立大学法人大阪大学 | 関節炎の予防又は治療剤 |
JP6893586B2 (ja) | 2019-01-24 | 2021-06-23 | 国立大学法人大阪大学 | 薬剤及びその製造方法 |
JP7461011B2 (ja) | 2019-01-24 | 2024-04-03 | 国立大学法人大阪大学 | 難聴の予防又は治療剤 |
JP7461004B2 (ja) | 2019-01-24 | 2024-04-03 | 国立大学法人大阪大学 | 記憶障害の予防又は治療剤 |
JP7461007B2 (ja) | 2019-01-24 | 2024-04-03 | 国立大学法人大阪大学 | 内臓不快感の予防又は治療剤 |
JP7461009B2 (ja) | 2019-01-24 | 2024-04-03 | 国立大学法人大阪大学 | 糖尿病の予防又は治療剤 |
JP7461005B2 (ja) | 2019-01-24 | 2024-04-03 | 国立大学法人大阪大学 | 自閉スペクトラム症の予防又は治療剤 |
JP7461008B2 (ja) | 2019-01-24 | 2024-04-03 | 国立大学法人大阪大学 | 脊髄損傷後の障害もしくは症状の予防又は治療剤 |
JP7461010B2 (ja) | 2019-06-06 | 2024-04-03 | 国立大学法人大阪大学 | 虚血性脳血管障害に伴う障害の予防又は治療剤 |
JPWO2021206020A1 (ja) * | 2020-04-06 | 2021-10-14 | ||
WO2021215364A1 (ja) * | 2020-04-23 | 2021-10-28 | 国立大学法人大阪大学 | 子宮内感染症の予防又は治療剤 |
WO2021215473A1 (ja) * | 2020-04-24 | 2021-10-28 | 国立大学法人大阪大学 | フレイルの予防又は治療剤 |
-
2022
- 2022-05-31 US US18/567,479 patent/US20240269165A1/en active Pending
- 2022-05-31 JP JP2023527628A patent/JPWO2022259907A1/ja active Pending
- 2022-05-31 CN CN202280038824.0A patent/CN117396212A/zh active Pending
- 2022-05-31 EP EP22820089.5A patent/EP4353241A4/en active Pending
- 2022-05-31 WO PCT/JP2022/022056 patent/WO2022259907A1/ja active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CN117396212A (zh) | 2024-01-12 |
EP4353241A1 (en) | 2024-04-17 |
EP4353241A4 (en) | 2024-09-18 |
WO2022259907A1 (ja) | 2022-12-15 |
US20240269165A1 (en) | 2024-08-15 |